Results 91 to 100 of about 10,873 (203)

Combination of ADAM17 knockdown with eplerenone is more effective than single therapy in ameliorating diabetic cardiomyopathy

open access: yesFrontiers in Pharmacology
BackgroundThe renin-angiotensin-aldosterone system (RAAS) members, especially Ang II and aldosterone, play key roles in the pathogenesis of diabetic cardiomyopathy (DCM).
Lin Xie   +6 more
doaj   +1 more source

Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats

open access: yes, 2004
We examined the effect of different levels of salt intake on the role of aldosterone on cardiac and vascular changes in salt-loaded stroke-prone spontaneously hypertensive rats (SHRSP). Eleven-week-old SHRSP were fed high-salt (4.2% NaCl), normal-salt (0.
Touyz, R.M.   +9 more
core   +1 more source

AZD9977 and eplerenone activities on MR, GR, PR and AR in binding assays.

open access: yes, 2018
AZD9977 and eplerenone activities on MR, GR, PR and AR in binding assays.
Anna Björnson Granqvist (4885225)   +13 more
core   +1 more source

Effects of eplerenone on resistance to antihypertensive medication in patients with primary or secondary hyperaldosteronism

open access: yes, 2017
Background and ObjectivesResistant hypertension is an important problem; nearly half of diagnosed hypertensives are not controlled to target blood pressure levels, and approximately 90% of strokes occur among patients with resistant hypertension. Primary
Daniel G. Hackam   +4 more
core   +1 more source

Postpartum administration of eplerenone to mitigate vascular dysfunction in mice following a preeclampsia-like pregnancy

open access: yesScientific Reports
Preeclampsia is a severe pregnancy complication associated with substantial injury to systemic vasculature, major organs, and the feto-placental unit, with an approximate mortality rate of 76,000 pregnant women and 500,000 babies each year.
Natalie K. Binder   +7 more
doaj   +1 more source

AZD9977 and eplerenone activities in reporter gene assays.

open access: yes, 2018
Concentration response curves of AZD9977 and eplerenone tested in a reporter gene assay in (a) presence or (b) absence of 0.1 nM aldosterone. n = 4, average ± SD.
Anna Björnson Granqvist (4885225)   +13 more
core   +1 more source

AZD9977 and eplerenone activities in reporter gene assays for human, mouse and rat MR.

open access: yes, 2018
AZD9977 and eplerenone activities in reporter gene assays for human, mouse and rat MR.
Anna Björnson Granqvist (4885225)   +13 more
core   +1 more source

Eplerenone in chronic heart failure with depressed systolic function

open access: yes, 2015
Eplerenone is a selective mineralocorticoid receptor antagonist that has been recently included in the treatment of patients with chronic heart failure (CHF) and reduced systolic function.
Volterrani M., Iellamo F.
core   +1 more source

Adverse events associated with early initiation of Eplerenone in patients hospitalized for acute heart failure

open access: yes
International audience Eplerenone did not elevate rates of WRF, hyperkalemia, hypotension and dehydration. Baseline HF severity and comorbidity burden were associated with adverse events.
Kitakaze, Masafumi   +7 more
core   +1 more source

The long-term antiproteinuric effect of eplerenone, a selective aldosterone blocker, in patients with non-diabetic chronic kidney disease

open access: yes, 2011
Introduction: There is still insufficient data concerning the clinical effects of eplerenone, a selective aldosterone blocker, in patients with non-diabetic chronic kidney disease (CKD).
Nobuo Tsuboi   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy